Application no. and date | 17191118.3 (espacenet) (Federated) (European Patent Register), 20091106 | Patent/reg. no. and date | DK/EP 3290052, 20191225 | Publication date | 20180307 | Priority no. and date | US 112686 P, 20081107, US 164870 P, 20090330 | EP pub. no. and date |
EP 3290052 20180307 | Effective date | | Applicant/owner | Galaxy Biotech, LLC, 22830 San Juan Road
Cupertino CA 95014, US | Applicant ref. no. | V1912-074-DK | Inventor | Zhao, Wei-Meng, 104 Windsor Drive
San Carlos, CA 94070, US, KYUNG JIN, Kim, 22830 San Juan Road
Cupertino, CA 95014, US, PARK, Hangil, 1325 Indiana St. Unit 102
San Francisco, CA 94107, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) , C12P 21/08 (2006.01) , G01N 33/574 (2006.01) | Title | MONOKLONALE ANTISTOFFER MOD FIBROBLASTVÆKSTFAKTORRECEPTOR 2 | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|